Diabetes and CYP2C19 Polymorphism Synergistically Impair the Antiplatelet Activity of Clopidogrel Compared With Ticagrelor in Percutaneous Coronary Intervention–treated Acute Coronary Syndrome Patients

Acute Coronary Syndrome ◽

Coronary Intervention ◽

Antiplatelet Activity ◽

Coronary Syndrome ◽

Cyp2c19 Polymorphism ◽

Who was the culprit? Non-ST-elevation acute coronary syndrome treated with percutaneous coronary intervention and cangrelor infusion

Minerva Cardioangiologica ◽

10.23736/s0026-4725.19.04916-8 ◽

2019 ◽

Vol 67 (5) ◽

Author(s):

Marco Loffi ◽

Gianluca Galeazzi ◽

Giuseppe Di Tano ◽

Paolo Pedroni ◽

Enrico Passamonti

Keyword(s):

Acute Coronary Syndrome ◽

Coronary Intervention ◽

Coronary Syndrome ◽

Percutaneous Coronary ◽

St Elevation ◽

Elevation Acute Coronary Syndrome

The prognostic value of mean platelet volume to platelet count ratio in older patients with non-ST elevation acute coronary syndrome receiving primary percutaneous coronary intervention: a retrospective study

Minerva Cardioangiologica ◽

10.23736/s0026-4725.18.04836-3 ◽

2019 ◽

Vol 67 (2) ◽

Cited By ~ 1

Author(s):

Xiaoqiang Sun ◽

Heng Li ◽

Yankun Zhang ◽

Feng He ◽

Chengzhi Lu

Keyword(s):

Acute Coronary Syndrome ◽

Platelet Count ◽

Older Patients ◽

Prognostic Value ◽

Coronary Intervention ◽

Platelet Volume ◽

Coronary Syndrome ◽

Percutaneous Coronary ◽

St Elevation

Predictive factors for new-onset atrial fibrillation in acute coronary syndrome patients undergoing percutaneous coronary intervention

Panminerva Medica ◽

10.23736/s0031-0808.18.03556-5 ◽

2020 ◽

Vol 62 (1) ◽

Author(s):

Zhiyuan Zhang ◽

Chunfang Hu ◽

Ruzhu Wang ◽

Jie Lin ◽

Zhongbao Ruan

Keyword(s):

Atrial Fibrillation ◽

Acute Coronary Syndrome ◽

Predictive Factors ◽

Coronary Intervention ◽

Coronary Syndrome ◽

Percutaneous Coronary ◽

Onset Atrial Fibrillation ◽

New Onset

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Case Medical Research ◽

10.31525/ct1-nct04060914 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Coronary Syndrome ◽

Maintenance Dose ◽

Coronary Intervention ◽

Coronary Syndrome ◽

Faculty Opinions recommendation of Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737510857.793573001 ◽

2020 ◽

Author(s):

Wilbert Aronow

Keyword(s):

Myocardial Infarction ◽

Acute Coronary Syndrome ◽

Coronary Intervention ◽

Coronary Syndrome ◽

14 Antithrombotic therapy with or without aspirin after percutaneous coronary intervention or acute coronary syndrome in patients taking oral anticoagulation: a meta-analysis and network analysis of randomised controlled trials

10.1136/heartjnl-2020-ics.14 ◽

2020 ◽

Author(s):

R Colleran ◽

RA Byrne ◽

H Rai ◽

A Kastrati ◽

S Cassese

Keyword(s):

Acute Coronary Syndrome ◽

Network Analysis ◽

Randomised Controlled Trials ◽

Meta Analysis ◽

Coronary Intervention ◽

Controlled Trials ◽

Coronary Syndrome ◽

Percutaneous Coronary ◽

Randomised Controlled

Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Chinese Medical Journal ◽

10.4103/0366-6999.239306 ◽

2018 ◽

Vol 131 (17) ◽

pp. 2017-2024 ◽

Cited By ~ 2

Author(s):

He-Yang Wang ◽

Yi Li ◽

Xiao-Ming Xu ◽

Jing Li ◽

Ya-Ling Han

Keyword(s):

Acute Coronary Syndrome ◽

Bleeding Risk ◽

Coronary Intervention ◽

Chinese Patients ◽

Efficacy And Safety ◽

Coronary Syndrome ◽

Acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention: pathophysiologies, risk factors and preventive measures

Cardiology ◽

10.1159/000517991 ◽

2021 ◽

Author(s):

Ya-feng Zhang ◽

Da-dong Liu ◽

Yue Zhou ◽

Ji-zhuang Lou

Keyword(s):

Risk Factors ◽

Acute Kidney Injury ◽

Acute Coronary Syndrome ◽

Preventive Measures ◽

Kidney Injury ◽

Coronary Intervention ◽

Coronary Syndrome ◽

OUTPATIENT TRENDS IN DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME AND PRIMARY PERCUTANEOUS CORONARY INTERVENTION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(17)34408-x ◽

2017 ◽

Vol 69 (11) ◽

pp. 1019 ◽

Cited By ~ 1

Author(s):

Ron Waksman ◽

Kyle Buchanan ◽

M. Chadi Alraies ◽

Toby Rogers ◽

Arie Steinvil ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Antiplatelet Therapy ◽

Primary Percutaneous Coronary Intervention ◽

Dual Antiplatelet Therapy ◽

Coronary Intervention ◽

Coronary Syndrome ◽

WITHDRAWN: Relation of Mean Platelet Volume-to-Lymphocyte Ratio and Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

The American Journal of Cardiology ◽

10.1016/j.amjcard.2017.07.084 ◽

2017 ◽

Author(s):

Alparslan Kurtul ◽

Selcuk Ozturk

Keyword(s):

Acute Kidney Injury ◽

Acute Coronary Syndrome ◽

Mean Platelet Volume ◽

Kidney Injury ◽

Coronary Intervention ◽

Platelet Volume ◽

Lymphocyte Ratio ◽

Coronary Syndrome ◽